COHR COHERENT CORP.
Optical Instruments & Lenses · NYSE · SEC CIK 820318 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY30.8%
TTM net income YoY285.6%
TTM EPS YoY580.3%
Revenue 3-yr CAGR17.5%
Net income 3-yr CAGR—
Margins
Gross margin38.2%
Operating margin—
Net margin12.2%
FCF margin-23.2%
EBITDA margin—
Returns
ROE11.2%
ROA5.5%
ROIC (approx.)—
Asset turnover0.45x
Leverage & solvency
Liabilities / assets42.4%
Debt / equity0.35x
Current ratio2.29x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.06x
Accruals ratio5.9%
Payout ratio—
Capex / revenue22.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $7.12B | $5.81B |
| Cost of revenue | $4.45B | $3.77B |
| Gross profit | $2.67B | $2.04B |
| R&D expense | $722.95M | $581.92M |
| SG&A expense | $1.04B | $926.45M |
| Pretax income | $847.73M | $94.18M |
| Income tax | $60.85M | $64.12M |
| Net income | $805.00M | $49.36M |
| EPS (basic) | 4.34 | -0.52 |
| EPS (diluted) | 4.12 | -0.52 |
| Weighted avg. shares (diluted) | 195.39M | 154.75M |
| Balance sheet | ||
| Cash & equivalents | $1.16B | $1.63B |
| Short-term investments | $825.00M | $0 |
| Receivables | $1.34B | $964.05M |
| Inventory | $2.58B | $1.44B |
| Current assets | $6.93B | $3.93B |
| PP&E, net | $3.00B | $1.88B |
| Goodwill | $4.38B | $4.47B |
| Intangibles | $2.88B | $3.20B |
| Total assets | $18.30B | $14.91B |
| Current liabilities | $2.85B | $1.79B |
| Short-term debt | $7.92M | $188.31M |
| Long-term debt | $3.21B | $3.50B |
| Total debt | $3.22B | $3.69B |
| Total liabilities | $7.06B | $6.43B |
| Shareholders' equity | $10.90B | $5.64B |
| Net debt | $2.06B | $2.05B |
| Cash flow statement | ||
| Operating cash flow | $79.51M | $633.60M |
| Capital expenditure | $1.10B | $440.84M |
| Free cash flow | -$1.02B | $192.76M |
| Investing cash flow | -$1.41B | -$414.21M |
| Financing cash flow | $1.48B | -$451.73M |
| Depreciation & amortization | $521.89M | $553.60M |
| Stock-based compensation | $186.47M | $160.24M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.